Chinese Stocks To Consider - November 19th

Market Beat
2025.11.20 19:34
portai
I'm PortAI, I can summarize articles.

MarketBeat's stock screener tool highlights Diageo, UP Fintech, and China SXT Pharmaceuticals as key Chinese stocks to watch. Diageo engages in alcoholic beverage production, UP Fintech offers online brokerage services, and China SXT Pharmaceuticals focuses on traditional Chinese medicine. These stocks have high trading volumes recently. MarketBeat provides insights into top-rated stocks, though Diageo is not among the top five recommended by analysts.

  • Zoom Video Indicates Normalization Ends and Growth Resumes

Diageo, UP Fintech, and China SXT Pharmaceuticals are the three Chinese stocks to watch today, according to MarketBeat's stock screener tool. Chinese stocks are equity securities issued by companies based in China (including mainland China and Hong Kong) that investors can buy and sell on domestic and international exchanges. They encompass categories such as A‑shares (Shanghai/Shenzhen), B‑shares, H‑shares (Hong Kong), red chips, P‑chips and American Depositary Receipts (ADRs), which differ by listing venue, currency, regulatory regime and investor access. These companies had the highest dollar trading volume of any Chinese stocks within the last several days.

Diageo (DEO)

Diageo plc, together with its subsidiaries, engages in the production, marketing, and sale of alcoholic beverages. The company offers scotch, gin, vodka, rum, raki, liqueur, wine, tequila, Chinese white spirits, cachaça, and brandy, as well as beer, including cider and flavored malt beverages. It also provides Chinese, Canadian, Irish, American, and Indian-Made Foreign Liquor whiskies, as well as flavored malt beverages, ready to drink, and non-alcoholic products.

  • Modelo Sale Success Propels Constellation Brands In The Market

Read Our Latest Research Report on DEO

UP Fintech (TIGR)

UP Fintech Holding Limited provides online brokerage services focusing on Chinese investors. The company has developed a brokerage platform, which allows investor to trade stocks, options, warrants, and other financial instruments that can be accessed through its APP and website. It offers brokerage and value-added services, including investor education, community engagement, and IR platform services.

  • 3 Beer Stocks to Tap into if You're Ready for Some Football

Read Our Latest Research Report on TIGR

China SXT Pharmaceuticals (SXTC)

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as ChenXiang, SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, and ShaRen.

Read Our Latest Research Report on SXTC

Further Reading

  • MarketBeat's Top Five Stocks to Own in November 2025
  • 3 Data Center Stocks Are Soaring—Analysts Think 1 Could Go Higher
  • Why GRAIL Stock Could Be Biotech’s Next Big Breakout
  • Why Ford's Deal With Amazon Is Bigger Than You Think
  • Buyer Beware: Carvana Is Driving an Auto Lending Crisis
  • Healthcare Rotation Underway: 3 Stocks Leading the Charge

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Diageo Right Now?

Before you consider Diageo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diageo wasn't on the list.

While Diageo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here